《大行報告》富瑞下調大家樂(00341.HK)目標價至17元 評級「買入」
富瑞發表報告指,大家樂(00341.HK)將於11月底公布2023財年上半年業績,預期集團純利將按年增長34%至1.09億元,但銷售則倒退1%至38.7億元。若撇除其他收入,估計集團純利為下跌9%。
富瑞相信,大家樂上半財年的趨勢符合其三年計劃,雖然香港市場料可因防疫措施放寬而有所恢復,不過由於復甦前路更為緩慢,特別是中國市場,該行將集團2023至2025財年的盈利預測分別下調4.7%、4.8%及4.5%,股份目標價由17.41元降至17元,評級維持「買入」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.